Monday, March 27, 2017 11:41:51 PM
Testing using the Cannabix Marijuana Breathalyzer Beta prototype device with human subjects after smoking THC cigarettes demonstrated the successful detection of THC, the psychoactive component of marijuana, in real-time. In addition to THC, several metabolites were identified in the breath of the human subjects including 11-hydroxy-delta-9-tetrahydrocannabinol and delta-9-carboxy-tetrahydrocannabinol, and three other cannabinoids related to cannabigerol, were confirmed by mass spectrometry after the inhalation of cannabis.
From November 2014:
http://www.innovationews.com/science/bioscience/lifeloc-technologies-moves-to-develop-technology-to-test-marijuana-impairment/
Thanks in part to a $250,000 grant from the Colorado Office of Economic Development, Lifeloc scientists have come up with a method that can not only detect the presence of Delta 9 THC in a person's exhaled breath, it can also identify the metabolite separately.
"Feasibility of detection has already been demonstrated for very low levels of delta-9-THC, cocaine, and methamphetamine."
LCTC was pretty much demonstrating this same detection over 2 years ago according to that article.
I still have a hard time grasping how BLOZF is being valued at almost twice that of LCTC.
A nice 10 for 1 (or even 20 for 1) stock split and some updates on the marijuana breathalyzer progress being made would do this stock wonders. Most investors/bloggers/news services are not even included LCTC in the race when they have proven the same detection as BLOZF but did it over 2 years ago.
Recent LCTC News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:14:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:46:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 02:57:07 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/23/2023 02:57:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 09:11:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 08:21:40 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM